Latest ROE for Baird Medical Investment Holdings Limited: -55.05% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-55.05%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Baird Medical Investment Holdings Limited (BDMD) currently reports a ROE of -55.05%. That is below the sector sector average of -6.04%. Use the charts on this page to explore Baird Medical Investment Holdings Limited's ROE history and peer comparisons.
Baird Medical Investment Holdings Limited's ROE of -55.05% is lower than the its sector sector average of -6.04%. That is roughly 811.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Baird Medical Investment Holdings Limited's current -55.05% should be judged against industry norms (sector average: -6.04%) and against BDMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -55.05%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -6.04%. From there, open related valuation or income-statement pages for Baird Medical Investment Holdings Limited, and consider following BDMD for alerts when major investors trade the stock.